Skip to main content

Sex and Gender Differences in Pharmacology

  • Book
  • © 2012

Overview

  • Very first book to deal with sex and gender differences in drug therapy - an increasingly recognized medical need
  • Connection to large database on sex differences in drug effects
  • Clear key note messages by international experts
  • Includes supplementary material: sn.pub/extras
  • Includes supplementary material: sn.pub/extras

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 214)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (24 chapters)

  1. Sex Differences in Mechanisms of Disease

  2. Sex differences in mechanisms of disease

  3. Sex Differences in Pharmacokinetics, in Drug Development and Use

  4. Sex differences in pharmaco¬kinetics, in drug development and use.

  5. Sex Differences in Different Therapeutic Areas

  6. Sex differences in different therapeutic areas

Keywords

About this book

This is the very first book to deal with sex and gender differences in drug therapy - an increasingly recognized medical need. It starts with an overview on S/G in clinical syndromes and a documentation of the medical and socioeconomic damage caused by gender specific adverse drug effects. Part I covers S/G differences in pharmacokinetics. Researchers will be satisfied by the detailed discussion of the mechanisms of S/G differences in drug effects that represents cutting edge science and includes interaction of drugs with sex hormones, genomic and epigenetic mechanisms. It also covers S/G in drug development, in animal models and clinical development and S/G in drug prescriptions. Part II targets S/G differences in drug effects in cardiovascular, pulmonary, CNS, neuromuscular, neuropsychiatric and metabolic diseases, in cancer, inflammation, and rheumatic diseases, in bacterial and retroviral infections, thrombosis, embolism. New drugs will be discussed.

Editors and Affiliations

  • Institute of Gender in Medicine (GiM), Center for Cardiovascular Research (CCR), Charité - Universitätsmedizin Berlin, Berlin, Germany

    Vera Regitz-Zagrosek

Bibliographic Information

Publish with us